Search
Login
My Portfolios Login
TradeMachine® Login
CML Research Pro Login
Get TradeMachine®
Get CML Research
Compare Products
Home
My Portfolios
CMLViz News
Breaking
Stock
Scanner
Tear Sheet
News
Profile
Stats
Stock Chart
Pivot Points
Financial Charts
Holders
Analysts
Day Trader
Back-Tester
SPX
3,825.33
+40.17
(
+1.05%
)
Dow 30
+1.00%
QQQ
+0.66%
VIX
27.53
-1.18
(
-4.11%
)
United Therapeutics Corp
NASDAQ:UTHR 3:59:53 PM EDT
238.04
+2.40
(
+1.02%
)
Products
United Therapeutics Announces FDA Approval Of Tyvaso DPI
Published: 05/24/2022 10:14 GMT
UTHR
United Therapeutics Corp (
UTHR
)
- United Therapeutics Announces FDA Approval of Tyvaso Dpi™.
United Therapeutics Corp- Commercial Launch Activities Underway; Patient Availability Expected in June 2022.